Q4 2017 13F Holders as of 31 Dec 2017
-
Type / Class
-
Equity / American depositary shares, each representing one equity share
-
Shares outstanding
-
834,731,296
-
Number of holders
-
116
-
Total 13F shares, excl. options
-
21,751,667
-
Shares change
-
-1,012,319
-
Total reported value, excl. options
-
$816,953,752
-
Value change
-
-$37,479,890
-
Put/Call ratio
-
364%
-
Number of buys
-
37
-
Number of sells
-
-59
-
Price
-
$37.56
Significant Holders of DR REDDYS LABORATORIES LTD - American depositary shares, each representing one equity share (RDY) as of Q4 2017
134 filings reported holding RDY - DR REDDYS LABORATORIES LTD - American depositary shares, each representing one equity share as of Q4 2017.
DR REDDYS LABORATORIES LTD - American depositary shares, each representing one equity share (RDY) has 116 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 21,751,667 shares
of 834,731,296 outstanding shares and own 2.6% of the company stock.
Largest 10 shareholders include Fisher Asset Management, LLC (5,415,017 shares), ROYAL BANK OF CANADA (4,388,463 shares), Commonwealth Bank of Australia (1,738,727 shares), BlackRock Inc. (1,405,649 shares), Vanguard Group Inc (1,346,827 shares), STATE STREET CORP (642,788 shares), AQR CAPITAL MANAGEMENT LLC (630,105 shares), DIMENSIONAL FUND ADVISORS LP (582,904 shares), Mondrian Investment Partners LTD (356,786 shares), and DEUTSCHE BANK AG\ (339,601 shares).
This table shows the top 116 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.